{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:34:48Z","timestamp":1771482888019,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.2515\/therapie\/2010066","type":"journal-article","created":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T10:38:01Z","timestamp":1293014281000},"page":"525-532","source":"Crossref","is-referenced-by-count":17,"title":["Administration des m\u00e9dicaments par voie sous-cutan\u00e9e en soins palliatifs"],"prefix":"10.1016","volume":"65","author":[{"given":"Charlotte","family":"Tanguy-Goarin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Cogulet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie\/2010066_bb0005","article-title":"Les principales th\u00e9rapeutiques m\u00e9dicamenteuses en soins palliatifs","author":"Sang","year":"2001","journal-title":"Sauramps medical"},{"key":"10.2515\/therapie\/2010066_bb0010","first-page":"266","article-title":"Conseils pratiques. La voie sous-cutan\u00e9e. Une alternative utile en soins palliatifs","volume":"47","author":"Dugas","year":"2001","journal-title":"Le m\u00e9decin de famille canadien"},{"issue":"40","key":"10.2515\/therapie\/2010066_bb0015","first-page":"2246","article-title":"La perfusion sous-cutan\u00e9e ou hypodermoclyse : une technique de r\u00e9hydratation utile en g\u00e9riatrie","volume":"28","author":"Dardaine","year":"1999","journal-title":"Presse Med"},{"issue":"7","key":"10.2515\/therapie\/2010066_bb0020","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/106002809603000703","article-title":"Pain assessment of subcutaneous injections","volume":"30","author":"Jorgensen","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.2515\/therapie\/2010066_bb0025","first-page":"1","article-title":"Administration des m\u00e9dicaments et r\u00e9hydratation par voie sous-cutan\u00e9e","volume":"23","author":"D\u00e9partement de r\u00e9habilitation et g\u00e9riatrie. Pharmacie des H\u00f4pitaux universitaires de Gen\u00e8ve","year":"2003","journal-title":"CAPP-INFO"},{"key":"10.2515\/therapie\/2010066_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0248-8663(05)81381-5","article-title":"L\u2019hypodermoclyse : une technique oubli\u00e9e","volume":"12","author":"Dutertre","year":"1991","journal-title":"Rev Med Interne"},{"key":"10.2515\/therapie\/2010066_bb0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1532-5415.1991.tb05898.x","article-title":"Subcutaneous fluid administration in elderly subjects: Validation of an under-used technique","volume":"39","author":"Lipschitz","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"10.2515\/therapie\/2010066_bb0040","doi-asserted-by":"crossref","first-page":"M334","DOI":"10.1093\/gerona\/50A.6.M334","article-title":"Metabolic and hormonal changes induced by hypodermoclysis of a glucose-saline solution in elderly patients","volume":"50A","author":"Dardaine","year":"1995","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.2515\/therapie\/2010066_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/pgmj.70.821.195","article-title":"A comparison of intravenous and subcutaneous hydration in elderly acute stroke patients","volume":"70","author":"Challiner","year":"1994","journal-title":"Postgrad Med J"},{"key":"10.2515\/therapie\/2010066_bb0050","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1532-5415.1997.tb01515.x","article-title":"Comparison of subcutaneous and intravenous administration of a solution of amino-acids in older patients","volume":"45","author":"Ferry","year":"1997","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"10.2515\/therapie\/2010066_bb0055","first-page":"A53","article-title":"Antibioth\u00e9rapie et voie sous-cutan\u00e9e en g\u00e9riatrie","volume":"26","author":"Grumbach","year":"2001","journal-title":"La revue de g\u00e9riatrie"},{"issue":"5","key":"10.2515\/therapie\/2010066_bb0060","first-page":"193","article-title":"Administration des antibiotiques par voie sous-cutan\u00e9e : int\u00e9r\u00eats et limites","volume":"2","author":"Amrein","year":"1998","journal-title":"Pyrexie"},{"key":"10.2515\/therapie\/2010066_bb0065","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-2125.1996.03967.x","article-title":"Single-dose pharmacokinetics of ampicillin and tobramycin administered by hypodermoclysis in young and older healthy volunteers","volume":"42","author":"Champoux","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"10.2515\/therapie\/2010066_bb0070","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.lpm.2008.07.018","article-title":"Antibiotiques par voie sous-cutan\u00e9e chez la personne \u00e2g\u00e9e","volume":"38","author":"Robelet","year":"2009","journal-title":"Presse Med"},{"key":"10.2515\/therapie\/2010066_bb0075","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s00134-003-1859-z","article-title":"Pharmacokinetics and pharmacodynamics of sequential intravenous and subcutaneous teicoplanin in critically ill patients without vasopressors","volume":"29","author":"Barbot","year":"2003","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.2515\/therapie\/2010066_bb0080","first-page":"55","article-title":"Les m\u00e9dicaments injectables utilisables par voie souscutan\u00e9e : revue de la bibliographie","volume":"29","author":"Hoskovec","year":"2004","journal-title":"Revue de l\u2019ADPHSO"},{"key":"10.2515\/therapie\/2010066_bb0085","first-page":"21","article-title":"Pour une s\u00e9dation vigile non euthanasique. Midazolam et m\u00e9thotrimeprazine, alternatives \u00e0 l\u2019euthanasie","volume":"43","author":"Burucoa","year":"1996","journal-title":"Infokara"},{"issue":"634","key":"10.2515\/therapie\/2010066_bb0090","first-page":"1631","article-title":"Pratiquer une s\u00e9dation en soins palliatifs. La revue du praticien","volume":"17","author":"Blanchet","year":"2003","journal-title":"M\u00e9decine g\u00e9n\u00e9rale"},{"issue":"4","key":"10.2515\/therapie\/2010066_bb0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0885-3924(90)90020-K","article-title":"Subcutaneous midazolam infusion in palliative care","volume":"5","author":"Bottomley","year":"1990","journal-title":"J Pain Symptom Manage"},{"key":"10.2515\/therapie\/2010066_bb0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/026921638900300411","article-title":"The use of subcutaneous midazolam in the home care setting","volume":"3","author":"Amesbury","year":"1989","journal-title":"Palliat Med"},{"key":"10.2515\/therapie\/2010066_bb0105","first-page":"5","article-title":"Utilisation du midazolam en unit\u00e9 de soins palliatifs","volume":"43","author":"Lecomte","year":"1996","journal-title":"Infokara"},{"issue":"6","key":"10.2515\/therapie\/2010066_bb0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0885-3924(98)00020-7","article-title":"Indications and limitations of intravenous and subcutaneous midazolam in a palliative care center","volume":"15","author":"Gremaud","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.2515\/therapie\/2010066_bb0115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2125.2002.01665.x","article-title":"Absolute bioavailability of midazolam after subcutaneous administration to healthy volunteers","volume":"54","author":"Pecking","year":"2002","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.2515\/therapie\/2010066_bb0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/026921639400800307","article-title":"Plasma concentrations of midazolam during continuous subcutaneous administration in palliative care","volume":"8","author":"Bleasel","year":"1994","journal-title":"Palliat Med"},{"key":"10.2515\/therapie\/2010066_bb0125","unstructured":"Agence Fran\u00e7aise de S\u00e9curit\u00e9 Sanitaire des Produits de Sant\u00e9. Soins palliatifs : sp\u00e9cificit\u00e9 d\u2019utilisation des m\u00e9dicaments courants hors antalgiques. Recommandations. 25\/10\/2002, http:\/\/www.afssaps.fr (rubrique infos de s\u00e9curit\u00e9\/recommandations de bonnes pratiques)"},{"key":"10.2515\/therapie\/2010066_bb0130","first-page":"1","article-title":"Glucocortico\u00efdes injectables en soins palliatifs g\u00e9riatriques","volume":"20","author":"D\u00e9partement de r\u00e9habilitation et g\u00e9riatrie. Pharmacie des H\u00f4pitaux universitaires de Gen\u00e8ve","year":"2003","journal-title":"CAPP-INFO"},{"issue":"5","key":"10.2515\/therapie\/2010066_bb0135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jpainsymman.2004.02.002","article-title":"The compatibility and stability of midazolam and dexamethasone in infusion solutions","volume":"27","author":"Good","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.2515\/therapie\/2010066_bb0140","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2710.2007.00839.x","article-title":"Compatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patients","volume":"32","author":"Negro","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"10.2515\/therapie\/2010066_bb0145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1191\/0269216304pm1006oa","article-title":"Subcutaneous administration of drugs in the elderly: survey of practice and systematic literature review","volume":"19","author":"Fonzo-Christe","year":"2005","journal-title":"Palliat Med"},{"issue":"29","key":"10.2515\/therapie\/2010066_bb0150","article-title":"Constipation et obstruction intestinale chez le patient en soins palliatifs. \u00c9valuation et traitement","author":"H\u00f4pitaux universitaires de Gen\u00e8ve","year":"2004","journal-title":"CAPP-INFO"},{"key":"10.2515\/therapie\/2010066_bb0155","first-page":"553","article-title":"Plasma concentrations of fentanyl with subcutaneous infusion in palliative care patients","volume":"40","author":"Miller","year":"1995","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.2515\/therapie\/2010066_bb0160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0885-3924(99)00051-2","article-title":"A comparison of subcutaneous morphine and fentanyl in hospice cancer patients","volume":"18","author":"Hunt","year":"1999","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"10.2515\/therapie\/2010066_bb0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0304-3959(95)00084-6","article-title":"Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management","volume":"63","author":"Paix","year":"1995","journal-title":"Pain"},{"key":"10.2515\/therapie\/2010066_bb0170","series-title":"Nefopam: Ein neuartiges Analgetikum: Workshop in Bad Nauheim (Drug development and evaluation)","first-page":"122","article-title":"Behandlung postoperativer schmerzen nach Oberbauchoperationem mit nefopam","author":"Niederer","year":"1979"},{"issue":"1","key":"10.2515\/therapie\/2010066_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00520-006-0101-2","article-title":"Tramadol and hyoscine N-butyl bromide combined in infusion solutions: compatibility and stability","volume":"15","author":"Barcia","year":"2007","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.2515\/therapie\/2010066_bb0180","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jpainsymman.2005.02.011","article-title":"Stability of tramadol and haloperidol for continuous subcutaneous infusion at home","volume":"30","author":"Negro","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.2515\/therapie\/2010066_bb0185","doi-asserted-by":"crossref","first-page":"906","DOI":"10.7326\/0003-4819-119-9-199311010-00007","article-title":"Subcutaneous morphine for dyspnea in cancer patients","volume":"119","author":"Bruera","year":"1993","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.2515\/therapie\/2010066_bb0190","doi-asserted-by":"crossref","first-page":"692","DOI":"10.7326\/0003-4819-120-8-199404150-00016","article-title":"Morphine for dyspnea in patients with cancer","volume":"120","author":"Krasnow","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.2515\/therapie\/2010066_bb0195","first-page":"61","article-title":"Prise en charge pharmacologique de la dyspn\u00e9e chez le patient atteint d\u2019un cancer avanc\u00e9","volume":"4","author":"Beauverd","year":"2005","journal-title":"Med Pal"},{"issue":"1","key":"10.2515\/therapie\/2010066_bb0200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpainsymman.2005.06.009","article-title":"Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer","volume":"31","author":"Navigante","year":"2006","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10.2515\/therapie\/2010066_bb0205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jpainsymman.2006.12.001","article-title":"Midazolam as adjunct therapy to morphine to relieve dyspnea","volume":"33","author":"Sironi","year":"2007","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"10.2515\/therapie\/2010066_bb0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5055\/jom.2005.0008","article-title":"Morphine prescription to terminally ill patients with lung cancer and dyspnea: French physicians\u2019 attitude","volume":"1","author":"Ben Diane","year":"2005","journal-title":"Journal of opioid management"},{"key":"10.2515\/therapie\/2010066_bb0215","first-page":"61","article-title":"Prise en charge pharmacologique de la dyspn\u00e9e chez le patient atteint d\u2019un cancer avanc\u00e9","volume":"4","author":"Beauverd","year":"2005","journal-title":"Med Pal"},{"issue":"8800","key":"10.2515\/therapie\/2010066_bb0220","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/0140-6736(92)90584-P","article-title":"Subcutaneous ondansetron","volume":"339","author":"Mulvenna","year":"1992","journal-title":"Lancet"},{"issue":"3","key":"10.2515\/therapie\/2010066_bb0225","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5694\/j.1326-5377.1993.tb137805.x","article-title":"Ondansetron by subcutaneous infusion","volume":"159","author":"Philipot","year":"1993","journal-title":"Med J Aust"},{"issue":"1","key":"10.2515\/therapie\/2010066_bb0230","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1213\/00000539-199607000-00042","article-title":"Improved outcome with chronic subcutaneous infusion of ondansetron for intractable nausea and vomiting","volume":"83","author":"Macario","year":"1996","journal-title":"Anest Analg"},{"key":"10.2515\/therapie\/2010066_bb0235","first-page":"167","article-title":"The palliation of nausea and vomiting with ondansetron","volume":"6","author":"Hunt","year":"1992","journal-title":"Palliat Med"},{"issue":"5","key":"10.2515\/therapie\/2010066_bb0240","first-page":"265","article-title":"Antiemetic efficacy of subcutaneous 5-HT3 receptor antagonists in terminal care patients","volume":"15","author":"Porcel","year":"1998","journal-title":"J Pain Symptom Manage"},{"issue":"4 Suppl1","key":"10.2515\/therapie\/2010066_bb0245","first-page":"S24","article-title":"Safety and efficacy of ondansetron therapy for nausea and vomiting of pregnancy","volume":"99","author":"McCauley","year":"2002","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.2515\/therapie\/2010066_bb0250","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(25)20361-5","article-title":"Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics","volume":"258","author":"Mac Callum","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.2515\/therapie\/2010066_bb0255","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0885-3924(05)80007-7","article-title":"Subcutaneous infusions for control of cancer symptoms","volume":"5","author":"Storey","year":"1990","journal-title":"J Pain Symptom Manage"},{"key":"10.2515\/therapie\/2010066_bb0260","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1345\/aph.1D332","article-title":"Diuretic effects of subcutaneous furosemide in volunteers: a randomized pilot study","volume":"38","author":"Verma","year":"2004","journal-title":"Ann Pharmacother"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059571630720X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059571630720X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T01:19:28Z","timestamp":1740791968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004059571630720X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S004059571630720X"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2010066","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}